EUIPOProtect this trademark from copycats!
With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.
The Union trademark ONCOLYTIC IMMUNOTHERAPY was filed as Word mark on 09/13/2024 at the European Union Intellectual Property Office. The current status of the mark is "Application withdrawn".
| Trademark form | Word mark |
| File reference | 019079061 |
| Application date | September 13, 2024 |
Trademark owner
400 Spectrum Center Dr., Suite 2040
92618 Irvine, CA
US
92618 Irvine, CA
US
Trademark representatives
Avenida Federico Soto 13
03003 Alicante
ES
goods and services
5
Pharmaceutical products for the treatment of cancer; pharmaceutical preparations and biological preparations for the treatment of cancer and immunological disorders; Biopharmaceuticals for the treatment of cancer, namely, antibodies, non-antibody proteins, blood and blood components, stem cells, hormones, blood factors, tumor necrosis factors; Chemical preparations for medical or pharmaceutical purposes, namely, for cancer treatment, oncology and immunotherapy for auto immune diseases; Pharmaceutical products, namely, diagnostic kits consisting primarily of monoclonal antibodies, buffers, and reagents for use in disease testing
42
Pharmaceutical research and development; Providing medical and scientific research information in the fields of oncology, autoimmune disorders, immunotherapy, immunotherapeutics, biotechnology, biopharmaceuticals, pharmaceuticals, therapies, diseases, and disorders
Trademark history
| Date | Document number | Area | Entry |
|---|---|---|---|
| October 3, 2024 | Change Representative, Registered |
ID: 11019079061